Cargando…

Sex‐ and Race‐Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction

BACKGROUND: Sex and race have emerged as important contributors to the phenotypic heterogeneity of heart failure with preserved ejection fraction (HFpEF). However, there remains a need to identify important sex‐ and race‐related differences in characteristics and outcomes using a nationally represen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyal, Parag, Paul, Tracy, Almarzooq, Zaid I., Peterson, Janey C., Krishnan, Udhay, Swaminathan, Rajesh V., Feldman, Dmitriy N., Wells, Martin T., Karas, Maria G., Sobol, Irina, Maurer, Mathew S., Horn, Evelyn M., Kim, Luke K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532983/ https://www.ncbi.nlm.nih.gov/pubmed/28356281 http://dx.doi.org/10.1161/JAHA.116.003330

Ejemplares similares

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Hospital market concentration and the use of mechanical circulatory support devices in acute myocardial infarction complicated by cardiogenic shock
por: Vohra, Adam S., et al.
Publicado: (2022)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes
por: MCCULLOUGH, S. ANDREW, et al.
Publicado: (2020)

All-Cause Mortality as an End Point for Heart Failure With Preserved Ejection Fraction: Underperformance or Overambitious?
por: GOYAL, PARAG, et al.
Publicado: (2022)

Virtual Learning During the COVID-19 Pandemic: A Disruptive Technology in Graduate Medical Education
por: Almarzooq, Zaid I., et al.
Publicado: (2020)

Syncope in older adults
por: Goyal, Parag, et al.
Publicado: (2016)

Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
por: Jang, Sun-Joo, et al.
Publicado: (2021)

Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014
por: Jang, Sun-Joo, et al.
Publicado: (2023)

A Challenging Case of Extensive Spontaneous Coronary Artery Dissection
por: Narula, Nupoor, et al.
Publicado: (2020)

Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study
por: Sharma, Kavita, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Causes and Temporal Patterns of 30‐Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction
por: Goyal, Parag, et al.
Publicado: (2018)

Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction
por: Vullaganti, Sirish, et al.
Publicado: (2014)

Characterization of the inflammatory‐metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease
por: Packer, Milton, et al.
Publicado: (2020)

Partial Atrioventricular Canal Defect With an Anomalous Left Circumflex Coronary Artery in an Elderly Veteran
por: Almarzooq, Zaid, et al.
Publicado: (2019)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Meta‐Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction
por: Rich, Jonathan D., et al.
Publicado: (2018)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Attrition in longitudinal randomized controlled trials: home visits make a difference
por: Peterson, Janey C, et al.
Publicado: (2012)

The Adaptive Neuroplasticity Hypothesis of Behavioral Maintenance
por: Peterson, Janey C.
Publicado: (2012)

Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction
por: Jearath, Vaneet, et al.
Publicado: (2016)

The Single Match: Reflections on the National Resident Matching Program’s Sustained Partnership With Learners
por: Almarzooq, Zaid I., et al.
Publicado: (2021)

Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort
por: Fudim, Marat, et al.
Publicado: (2022)

In‐Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry
por: Feldman, Dmitriy N., et al.
Publicado: (2019)

Slow but steady wins the drug race
por: Wells, William A.
Publicado: (2004)

Left Atrial Ejection Force as a Marker for the Diagnosis of Heart Failure with Preserved Ejection Fraction
por: Hafez, Mohamed Saber, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance
por: Goliasch, Georg, et al.
Publicado: (2015)

Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report
por: Mahmood, Syed S., et al.
Publicado: (2018)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2021)

Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database
por: Jha, Anil Kumar, et al.
Publicado: (2022)

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
por: Abernethy, Abraham, et al.
Publicado: (2018)

Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
por: Kanagala, Prathap, et al.
Publicado: (2019)

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
por: Yang, Eunice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7l2ihsnd9oib1cv1h552iaqm2